While HIV/AIDS treatment innovations continue to emerge at a brisk rate, a number of clinical challenges persist. Chief among these are selection of an initial regimen that ensures optimal efficacy while minimizing the potential for adverse events and the development of viral resistance; individualizing therapy for all patients, including those with common comorbidities; and utilizing treatment and patient-centered approaches to improve adherence. Using a case-based format, this educational activity will address some of the ongoing challenges in HIV care and will demonstrate how the latest evidence should be applied to practice.

Educational Objectives:

At the conclusion of this educational activity, participants should be better able to:

• Apply the most recent data to selecting an individualized antiretroviral regimen for a treatment-experienced patient with HIV
• Utilize tools and interventions to facilitate therapeutic adherence
• Review current treatment guidelines and recent recommendations for optimal use of antiretroviral (ARV) therapy in patients co-infected with HIV and hepatitis C virus (HCV)
• Implement effective treatment strategies for a patient co-infected with HIV and HCV
• Identify predictors of poor adherence to highly active antiretroviral therapy (HAART)
• Apply the most recent data relevant to selecting an individualized HAART regimen for a treatment-naive patient with HIV

PROGRAM CHAIR
Richard A. Elion, MD
Director of Clinical Research
Whitman-Walker Health
Associate Clinical Professor of Medicine
Associate Attending Physician
The George Washington
University School of Medicine
Washington, DC



PROGRAM FACULTY
W. David Hardy, MD
Director, Division of Infectious Diseases
Cedars-Sinai Medical Center
Associate Professor of Medicine-in-Residence
David Geffen School of Medicine at UCLA
Los Angeles, CA




Edwin DeJesus, MD, FACP
Medical Director
Principal Investigator
Orlando Immunology Center
Orlando, FL




CME COURSE ADVISOR
Carol Harris, MD, MSc
Professor of Clinical Medicine
Division of Infectious Diseases
Director, Institute of Global HIV Medicine
Albert Einstein College of Medicine